Comparison of HCG Triggering Versus HCG in Combination with a GnRH Agonist: a Prospective Randomized Controlled Trial

Overview

Journal Facts Views Vis Obgyn

Specialty Gynecology & Obstetrics

Date 2015 Jan 17

PMID 25593695

Citations 25

Authors

W Decleer

K Osmanagaoglu

B Seynhave

S Kolibianakis

B Tarlatzis

P Devroey

Affiliations

Soon will be listed here.

Abstract

A prospective randomized controlled trial comparing two groups of ICSI (intra-cytoplasmatic sperm injection) patients with a different form of triggering the final oocyte maturation has been performed. All patients received an ovarian stimulation for in vitro fertilisation (IVF) using an antagonist protocol using recombinant-FSH -(rec-FSH) and Ganirelix. 120 Patients were randomized into two groups with similar clinical parameters. The first group had triggering with hCG, whereas the second group received a combination of hCG + GnRH agonist (Gonadotropin Releasing Hormone). As the primary endpoint, the number of metaphase II oocytes were analysed, the secondary endpoints were the number of cumulus oocyte complexes (COC), the number of fertilized oocytes, embryo morphology, pregnancy rate and the number of cryopreserved embryos. The mean number of MII oocytes in the hCG triggered group was 9.2 compared with 10.3 in the hCG-GnRH agonist group. There was no statistically significant difference in the number of COCs or pregnancy rates. However, the number of patients who received at least one embryo of excellent quality was significantly higher (p = 0.001) in the group with the combined triggering (45 out of 61 patients or 73.8%) versus the group with hCG triggering alone (28 out of 59 patients or 47.5%). The number of cryopreserved embryos was also higher in this group.

Citing Articles

Triggering final follicular maturation for IVF cycles.

Orvieto R Reprod Biol Endocrinol. 2025; 23(Suppl 1):12.

PMID: 39844247 PMC: 11755857. DOI: 10.1186/s12958-024-01332-5.

Reproductive Outcomes of Dual Trigger versus hCG Alone in Women Undergoing In Vitro Fertilization with Fresh Embryo Transfer Cycles.

Guner F, Ozekinci M, Mendilcioglu I, Kasabali Z Obstet Gynecol Int. 2024; 2024:9972437.

PMID: 39015476 PMC: 11251794. DOI: 10.1155/2024/9972437.

Comparison of pregnancy outcomes in women with normal ovarian response to the gonadotropin-releasing hormone agonist protocol using different trigger methods: a single-center retrospective cohort study based on propensity score matching.

Guo D, Pang C, Wang K Arch Gynecol Obstet. 2024; 309(5):2153-2165.

PMID: 38494512 DOI: 10.1007/s00404-024-07404-6.

Dual trigger for final oocyte maturation in expected normal responders with a high immature oocyte rate: a randomized controlled trial.

Yan M, Sun Z, Song J Front Med (Lausanne). 2023; 10:1254982.

PMID: 37869157 PMC: 10585044. DOI: 10.3389/fmed.2023.1254982.

Dual trigger and the impact on oocyte quality and embryo development: a Brazilian cohort.

Kozlowski I, Rosa V, Francisquini C, Schuffner A JBRA Assist Reprod. 2023; .

PMID: 37768818 PMC: 10718541. DOI: 10.5935/1518-0557.20230048.

References

Lin M, Wu F, Lee R, Li S, Lin S, Hwu Y . Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril. 2013; 100(5):1296-302. DOI: 10.1016/j.fertnstert.2013.07.1976. View

Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes J . Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril. 1991; 56(2):213-20. View

Kol S, Humaidan P . LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango?. Reprod Biomed Online. 2010; 21(5):590-2. DOI: 10.1016/j.rbmo.2010.06.031. View

Devroey P, Polyzos N, Blockeel C . An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011; 26(10):2593-7. DOI: 10.1093/humrep/der251. View

Humaidan P, Kol S, Papanikolaou E . GnRH agonist for triggering of final oocyte maturation: time for a change of practice?. Hum Reprod Update. 2011; 17(4):510-24. DOI: 10.1093/humupd/dmr008. View

Fatemi H, Kyrou D, Bourgain C, Van den Abbeel E, Griesinger G, Devroey P . Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. Fertil Steril. 2010; 94(6):2054-8. DOI: 10.1016/j.fertnstert.2009.11.036. View

Morley L, Tang T, Yasmin E, Hamzeh R, Rutherford A, Balen A . Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial. Hum Fertil (Camb). 2012; 15(3):134-9. DOI: 10.3109/14647273.2012.712739. View

Albano C, Grimbizis G, Smitz J, Riethmuller-Winzen H, Reissmann T, VAN Steirteghem A . The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. Fertil Steril. 1998; 70(2):357-9. DOI: 10.1016/s0015-0282(98)00135-6. View

Humaidan P, Bredkjaer H, Bungum L, Bungum M, Grondahl M, Westergaard L . GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2005; 20(5):1213-20. DOI: 10.1093/humrep/deh765. View

10.

Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S . Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective.... Fertil Steril. 2011; 95(6):2029-33, 2033.e1. DOI: 10.1016/j.fertnstert.2011.01.163. View

11.

Kolibianakis E, Albano C, Camus M, Tournaye H, Van Steirteghem A, Devroey P . Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril. 2004; 82(1):102-7. DOI: 10.1016/j.fertnstert.2004.01.027. View

12.

DiLuigi A, Engmann L, Schmidt D, Maier D, Nulsen J, Benadiva C . Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting. Fertil Steril. 2010; 94(3):1111-4. DOI: 10.1016/j.fertnstert.2009.10.034. View

13.

Schachter M, Friedler S, Ron-El R, Zimmerman A, Strassburger D, Bern O . Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertil Steril. 2007; 90(4):1087-93. DOI: 10.1016/j.fertnstert.2007.07.1316. View

14.

Polyzos N, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V . Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012; 27(12):3481-6. DOI: 10.1093/humrep/des318. View

15.

Shapiro B, Daneshmand S, Restrepo H, Garner F, Aguirre M, Hudson C . Efficacy of induced luteinizing hormone surge after "trigger" with gonadotropin-releasing hormone agonist. Fertil Steril. 2010; 95(2):826-8. DOI: 10.1016/j.fertnstert.2010.09.009. View

16.

Kol S, Humaidan P . GnRH agonist triggering: recent developments. Reprod Biomed Online. 2013; 26(3):226-30. DOI: 10.1016/j.rbmo.2012.11.002. View

17.

Kyrou D, Kolibianakis E, Fatemi H, Tarlatzis B, Tournaye H, Devroey P . Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective.... Fertil Steril. 2011; 96(5):1112-5. DOI: 10.1016/j.fertnstert.2011.08.029. View

18.

Hoff J, Quigley M, Yen S . Hormonal dynamics at midcycle: a reevaluation. J Clin Endocrinol Metab. 1983; 57(4):792-6. DOI: 10.1210/jcem-57-4-792. View

19.

Griesinger G, von Otte S, Schroer A, Ludwig A, Diedrich K, Al-Hasani S . Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum Reprod. 2007; 22(5):1348-52. DOI: 10.1093/humrep/dem006. View

20.

Griesinger G, Diedrich K, Devroey P, Kolibianakis E . GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update. 2005; 12(2):159-68. DOI: 10.1093/humupd/dmi045. View